Hyderabad-based Aurobindo Pharma’s Rs 171 crore acquisition of Veritaz Healthcare is unlikely to add much value to its business. It is nonetheless a stepping stone in the drug firm’s strategic
Aurobindo's Veritaz acquisition unlikely to add much value: Analysts
Deal is nonetheless a stepping stone in the drug firm's strategic plan to focus on domestic formulations market, where it aims to have Rs 1,000-cr sales in three years
 "Aurobindo Pharma")
Premium
Aurobindo Pharma | Photo: Wikipedia
Topics : Aurobindo Pharma acquisition
First Published: Mar 29 2022 | 4:42 PM IST
Key stories on business-standard.com are available only to BS Premium subscribers.
Register to read more on Business-Standard.com
